| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/30/2008 | CN101229228A Medicine compounds for treating angiitis, phlebitis, osteomyelitis and preparing method thereof |
| 07/30/2008 | CN101229226A Novel technology of extracting salvianic acid from salvia miltiorrhiza |
| 07/30/2008 | CN101229221A Chinese traditional medicine for treating thromboangiitis obliterans and preparing method thereof |
| 07/30/2008 | CN101229213A Rhodiola rosea compound healthy product |
| 07/30/2008 | CN101229208A Medicine for preventing and treating hypertension and preparing method thereof |
| 07/30/2008 | CN101229200A Medicine for curing cardio-cerebrovascular disease and preparing method thereof |
| 07/30/2008 | CN101229197A Uses of Huatuo reforger pill on preparing anemic heart disease preventing and curing medicine |
| 07/30/2008 | CN101229179A Medicine compounds containing oil orange phlorizin-B and uses thereof |
| 07/30/2008 | CN101229163A Medicine compounds containing levamlodipine and pitavastatin |
| 07/30/2008 | CN101229161A Medicine compounds containing levamlodipine beaylate and benazepril |
| 07/30/2008 | CN101229160A Antihypertensive medicine containing amlodipine besylate |
| 07/30/2008 | CN101229157A Calldesartan ci1exetil medicine compounds |
| 07/30/2008 | CN101229156A Medicine compounds used for cardiovascular disorders |
| 07/30/2008 | CN101229148A Glonoin Orally disintegrating tablets preparation of and preparing method thereof |
| 07/30/2008 | CN101229143A Amlodipine controlled release patch and preparing method thereof |
| 07/30/2008 | CN101229141A Aspirin sustained release tablet and preparing method thereof |
| 07/30/2008 | CN101229140A Nifedipine sustained release preparation and preparing method thereof |
| 07/30/2008 | CN101229134A Urapidil hydrochloride freeze-dried powder for injection and preparing method thereof |
| 07/30/2008 | CN101229132A Nimodipine pulse sustained release mircopill preparation and preparing method thereof |
| 07/30/2008 | CN101228936A Low calorific value bean paste and preparing method thereof |
| 07/30/2008 | CN101228918A Method of preparing walnut polypeptide powder |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406441C Cyclic amine compounds |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406427C Substituted phenylpropionic acid derivatives as agonists to human peroxisome proliferator-activated receptor alpha (ppar) |
| 07/30/2008 | CN100406054C Chinese-medicinal preparation for treating hypertension and preventing lesion |
| 07/30/2008 | CN100406044C Medicine for treating fracture and injury |
| 07/30/2008 | CN100406024C Preparing method for exogenous nitric oxide |
| 07/30/2008 | CN100406022C Use of adenyl and guanyl kind compound in preparing medicine or health protection product |
| 07/30/2008 | CN100406018C A nanometer 'Xue Sai Tong' injection and preparation method thereof |
| 07/30/2008 | CN100406015C Estradiol metabolites for the treatment of pulmonary hypertension |
| 07/29/2008 | US7405311 N-(trans-2,3-di-n-amyl-2-butenoic acid amide)-L-phenylglycinamide;treating hypertension, deficiency of magnesium ion bound to the plasma membranes of their somatic cells; sodium-sensitive essential hypertension and Type 2 insulin-resistant diabetes mellitus |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405300 Central nervous system disorders; cardiovascular disorders; antiischemic agents; strokes; antiarthritic agents; anticancer agents; muscular disorders |
| 07/29/2008 | US7405278 Chimeric human-type vascular endothelial cell growth factor |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405219 3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine; adenosine receptor antagonist; antidepressant, neurodegenerative disorders, cognition activator, attention deficit disorder |
| 07/29/2008 | US7405217 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7405196 administering a long acting insulin; also treating diabetic dyslipidemia and atherosclerosis in a patient with IFG, IGT or Type 2 diabetes, particularly early Type 2 diabetes |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | US7405049 Elevated concentration of given protein is indicative of sepsis or Alzheimer's disease; procalcitonin biomarker; immunoassay |
| 07/29/2008 | US7404952 ATP-binding cassette transporter polypeptide which regulates metabolism of triglycerides; treatment of obesity and eating disorders |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2387762C Process of making substituted pyrazoles |
| 07/29/2008 | CA2383600C Method for determining viability of a myocardial segment |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2376930C A method for the treatment or prevention of coronary graft vasospasm |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2337755C Inhibitors of p38 |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2333008C New heterocyclically substituted amides, their production and their use |
| 07/29/2008 | CA2295628C Stable formulations comprising a nucleotide and a freeze drying additive |
| 07/29/2008 | CA2272732C Hemorrhoidal treatment composition |
| 07/29/2008 | CA2262997C Pharmaceutical products for curing and preventing illnesses connected with the malfunction of vascular endothelial cells |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2223702C Therapeutic fragments of von willebrand factor |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2175767C Adhesion receptor antagonists |
| 07/29/2008 | CA2168192C 4-aminobenzoylguanidine derivatives |
| 07/24/2008 | WO2008089070A2 Combination therapy for the treatment of cancer |
| 07/24/2008 | WO2008089005A2 Renin inhibitors |
| 07/24/2008 | WO2008088047A1 Method for glycosylation of flavonoid |
| 07/24/2008 | WO2008088030A1 Composition for prevention or treatment of disease associated with thrombus or embolus |
| 07/24/2008 | WO2008088006A1 Ap2 inhibitor |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087401A1 Sulfate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087399A1 Mesylate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087397A1 Tosylate salts of irbesartan and their preparation and pharmaceutical compositions |
| 07/24/2008 | WO2008087371A1 New combination for use in the treatment of inflammatory disorders |
| 07/24/2008 | WO2008087248A1 Levosimendan for use in treating chronic valvular disease |
| 07/24/2008 | WO2008087178A1 Novel 1,4- and 1,5-diarylsubstituted 1,2,3-triazoles useful as potassium channel modulators |
| 07/24/2008 | WO2008087010A1 Use of nicotinamide for treatment and/or prevention of arteriosclerosis |
| 07/24/2008 | WO2008086733A1 New pharmaceutical composition |
| 07/24/2008 | WO2008070552A3 Inhibitors of protein tyrosine phosphatase for the promotion of physiological cardiac hypertrophy |
| 07/24/2008 | WO2008061329A3 PHα1B TOXIN, CDNA OF PHα1 B TOXIN GENE, PHARMACEUTICAL COMPOSITIONS CONTAINING PHα1B TOXIN, PROCESSES FOR THEIR OBTENTION AND PRODUCT |
| 07/24/2008 | WO2008049047A3 Quinoline compounds |
| 07/24/2008 | WO2008021375A3 Modulators of muscarinic receptors |
| 07/24/2008 | WO2007118051A3 Lipid therapy |
| 07/24/2008 | US20080177082 N3 alkylated benzimidazole derivatives as mek inhibitors |
| 07/24/2008 | US20080176961 Phosphodiesterase acitvity and regulation of phosphodiesterase 1-B-mediated signaling in brain |
| 07/24/2008 | US20080176959 Biodegradable polyphosphates complex for controlled release of bioactive substances and related methods |
| 07/24/2008 | US20080176947 5-Amino-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanoic acid prop-2-ynylamide; high potency; better bioavailability |
| 07/24/2008 | US20080176944 Elongase Genes and Uses Thereof |
| 07/24/2008 | US20080176934 for modifying fibrinolysis, for preventive and curative purposes with respect to thrombotic pathologies; inhibition of the expression of the PAI-1 gene |
| 07/24/2008 | US20080176918 Adrenergic stimulant; 4-[1-(2,3-dimethyl-phenyl)-ethyl]-1,3-dihydro-imidazole-2-thione; hypertension, glaucoma, spasticity, pain, attention deficit disorder |
| 07/24/2008 | US20080176916 A-amino-n-hydroxy-acetamide derivatives |
| 07/24/2008 | US20080176914 Crystal form of 2-(3-fluoro-4-hydroxyphenyl)-7-vinyl-1,3-benzoxazol-5-ol |
| 07/24/2008 | US20080176910 Methods for prevention and treatment of arteriosclerosis and restenosis |
| 07/24/2008 | US20080176909 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group |
| 07/24/2008 | US20080176899 Such as 1-Benzo[1,3]dioxol-5-yl-cyclopropanecarboxylic acid [5-(2-methoxy-pyridin-3-ylmethyl)-thiazol-2-yl]-amide 5-(2-Methoxy-pyridin-3-ylmethyl)-thiazol-2-ylamine; cystic fibrosis transmembrane conductance regulator disorders |
| 07/24/2008 | US20080176898 Leukotriene antagonists; cardiovascular disorders like unstable angina pectoris or myocardial infarction; Methyl 1-{[5-(ethoxycarbonyl)-2-(3-{4-[(4-isopropoxybenzyl)oxy]phenyl}propoxy)phenyl]-acetyl}piperidine-4-carboxylate |
| 07/24/2008 | US20080176886 Phenanthroindolizidine Alkaloids |
| 07/24/2008 | US20080176878 Crystalline rosuvastatin calcium |